Meet us at Menatox

14 March 2018
Meet us at Menatox

In 2017 it was reported that drug addiction in Oman was on the rise, with drug addicts in the country more than tripling from 2,000 to 6,500 in 6 years. However, due to the stigma surrounding drug addiction, the actual number of people addicted to drugs in Oman is expected to be much higher. The news prompted the country’s government to invest more than $200 million to expand their only current drug rehab facility over a 5 year period.

As the primary manufacture of Biochip Array Technology, Randox Toxicology provide cutting-edge multiplex testing capabilities offering rapid and accurate drug detection. Using our revolutionary Biochip Array Technology, the Evidence MultiSTAT is an automated analyser that enables on-site simultaneous detection of up to 21 classical, prescription and synthetic drugs of abuse from a single sample.

                                                        Evidence MultiSTAT

Evidence MultiSTAT
                                    - Fully automated benchtop immunoanalyser

                                    - Up to 132 tests per hour

                                    - Results generated in under 20 minutes

                                    - 2 steps from sample entry to results

                                             Click here for more information

Designed to work across a variety of matrices, our patented multi-analyte testing platform provides a complete immunoassay profile within minutes, changing the landscape of drug detection forever.

Visit our Business Development Executive Anil Padmanabhan at Menatox, 21st – 24th March 2018, to see demonstrations of the Evidence MultiSTAT, the most advanced screening technology on the market.

To arrange a meeting or find out more information email us at 

UK: +44 (0)28 9442 2413
USA: +1 304 728 2890